Given Imaging

Given Imaging (Hebrew: גיוון אימג'ינג) is an Israeli medical technology company that manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. Until March 2014, it was dual-listed on both the NASDAQ and the Tel Aviv Stock Exchange, where it was a component of the TA-100 Index and the TA BlueTech Index. In March 2014 it was acquired by Covidien and became a private company. In 2015 Covidien was purchased by Medtronic.

Given Imaging pioneered the capsule endoscopy technology and has also developed capsule-based pH monitoring. Through Sierra Scientific Instruments, a subsidiary, Given Imaging also provides an array of diagnostic modalities including high-resolution manometry and ambulatory reflux monitoring. Given Imaging's technology is currently marketed in over 60 countries.

History

Given Imaging was founded in 1998 by Gavriel Meron and Rafael Development Corporation (RDC) Ltd. based on the purchase of an early patent from Rafael Advanced Defense Systems Ltd. Initial funding for the company was provided by Elron Electronic Industries, Israel's leading technology holding company, in cooperation with Rafael. Today, Elron still holds 28% Given Imaging's shares. The idea for the solution was developed by Dr. Iddan, while working in the missile division of Rafael, where he envisioned that missile technology could be miniaturized to create a medical product.

The company's first capsule endoscopy products was named M2A capsule and received it CE marking in May 2001 and in August 2001 was cleared
by the US Food and Drug Administration (FDA) for visualization of abnormalities of the small intestine The capsule uses a radio developed for Given by Zarlink Semiconductor's medical team in San Diego and Jarfalla, Sweden.

In October 2001, Given Imaging had an Initial public offering on NASDAQ under ticker GIVN.) In September 2004, M2A capsule re-branded PillCam SB(R).

In March 2004, Given Imaging became a member of the Tel Aviv Stock Exchange

In November 2004, US FDA clears PillCam(R) ESO for the esophagus

In May 2006, US FDA clears Agile Patency System

In October 2006, PillCam COLON was cleared for marketing in the European Union (CE Mark)

In December 2008, Given Imaging acquired Bravo pH Monitoring System(R)

In May 2009, 1 millionth PillCam capsule was sold

In September 2009, PillCam COLON 2 receives CE Mark

In July 2012, Given Imaging's capsule endoscopy featured in a live broadcast on the BBC
...